F2Y-20333-46522
2 vaccinations
1 coded response
25 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 210 / MD
- Registered
- 2021-07-12
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-12
Registered in v-safe
-
2021-07-12
Dose 1 — Pfizer-BioNTech
- 2021-07-12
- 2021-07-13
-
2021-07-14
Survey response — days 1–6 daily, dose 1MedDRA: Fatigue — Feeling: GoodFree text: Yesterday was fatigue after my daily check in.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-15
- 2021-07-16
- 2021-07-17
- 2021-07-18
- 2021-07-19
- 2021-07-26
-
2021-08-02
Dose 2 — Pfizer-BioNTech
- 2021-08-02
- 2021-08-03
- 2021-08-04
- 2021-08-05
- 2021-08-06
- 2021-08-07
- 2021-08-08
- 2021-08-09
- 2021-08-16
- 2021-08-23
- 2021-08-30
- 2021-09-06
- 2021-09-13
- 2021-11-01
- 2022-01-31
- 2022-08-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-12 | Pfizer-BioNTech | No |
| 2 | 2021-08-02 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Yesterday was fatigue after my daily check in.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Fatigue | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release